Two trials show complexity of managing thromboembolism in Covid-19 patients

thrombosis
A Phase II ongoing trial sponsored by the Bill and Melinda Gates Foundation, is evaluating Xarelto in COVID-19 patients with mild disease who are at increased risk of disease progression. Credit: Victor Josan/Shutterstock.